JBIO (Jade Biosciences) ROCE %: -55.13% (As of Mar. 2026)


JBIO Jade Biosciences Inc JBIO
12 GF Score
Price $22.00
! 1 Warning Sign
View Full Analysis

What is Jade Biosciences ROCE %?

Jade Biosciences JBIO +0.87% 12 ROCE % is -55.13% as of Mar. 2026. GuruFocus rates JBIO with a GF Score™ of 12/100. The stock has 1 warning sign investors should review.

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Jade Biosciences's annualized ROCE % for the quarter that ended in Mar. 2026 was -55.13%.

Jade Biosciences  (NAS:JBIO) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Jade Biosciences ROCE % Related Terms

Jade Biosciences ROCE % Historical Data

* Premium members only.

The historical data trend for Jade Biosciences's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Jade Biosciences ROCE % Chart

Jade Biosciences Annual Data
Trend Dec24 Dec25
ROCE %
0.00 -57.63

Jade Biosciences Quarterly Data
Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
ROCE % Get a 7-Day Free Trial -153.83 -54.91 -57.32 -54.51 -55.13
JBIO
12GF Score
Jade Biosciences Inc JBIO
ROCE % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Jade Biosciences ROCE % Calculation

Jade Biosciences's annualized ROCE % for the fiscal year that ended in Dec. 2025 is calculated as:

ROCE %=EBIT/( (Capital Employed+Capital Employed)/ count )
(A: Dec. 2025 )  (A: Dec. 2024 )(A: Dec. 2025 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(A: Dec. 2025 )  (A: Dec. 2024 )(A: Dec. 2025 )
=-113.542/( ( (72.799 - 11.996) + (349.781 - 16.539) )/ 2 )
=-113.542/( (60.803+333.242)/ 2 )
=-113.542/197.0225
=-57.63 %

Jade Biosciences's ROCE % of for the quarter that ended in Mar. 2026 is calculated as:

ROCE %=EBIT (1)/( (Capital Employed+Capital Employed)/ count )
(Q: Mar. 2026 )  (Q: Dec. 2025 )(Q: Mar. 2026 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(Q: Mar. 2026 )  (Q: Dec. 2025 )(Q: Mar. 2026 )
=-173.78/( ( (349.781 - 16.539) + (319.433 - 22.292) )/ 2 )
=-173.78/( ( 333.242 + 297.141 )/ 2 )
=-173.78/315.1915
=-55.13 %

(1) Note: The EBIT data used here is four times the quarterly (Mar. 2026) EBIT data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about ROCE % →
What does a ROCE % of -55.13% mean?
Jade Biosciences (JBIO) has a ROCE % of -55.13% as of Mar. 2026.
Is Jade Biosciences' ROCE % too high?
Jade Biosciences' current ROCE % is -55.13%. Overall, Jade Biosciences has a GF Score™ of 12/100, reflecting its overall financial health beyond just this single metric.
How does Jade Biosciences' ROCE % compare to CRVS and ABSI?
Jade Biosciences' ROCE % of -55.13% can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROCE % for a Biotechnology company?
A good ROCE % depends on the Biotechnology industry context. However, ROCE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROCE % mean?
A high ROCE % can signal that a stock is expensive relative to its fundamentals. Jade Biosciences's current ROCE % is -55.13%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Jade Biosciences stock overvalued right now?
Jade Biosciences (JBIO) has a current ROCE % of -55.13%. The current ROCE % is -55.13%. Jade Biosciences' overall GF Score™ is 12/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROCE % calculated?
ROCE % is calculated from a company's financial statements. For Jade Biosciences (JBIO), the current ROCE % is -55.13% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Jade Biosciences Business Description

Address 221 Crescent Street, Building 23, Suite 105, Waltham, MA, USA, 02453
Jade Biosciences Inc is a clinical-stage biotechnology company focused on developing therapies for autoimmune diseases. Its flagship candidate, JADE101, targets the cytokine APRIL and is in a Phase 1 clinical trial for the treatment of immunoglobulin A nephropathy. The company's pipeline also includes JADE201, an afucosylated anti-BAFF-R monoclonal antibody, and JADE301, an antibody candidate in preclinical development.
12GF Score

Get the complete analysis for JBIO

ROCE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$22.00
Price